Comments
Loading...

EyePoint Pharmaceuticals

EYPTNASDAQ
Logo brought to you by Benzinga Data
$8.91
-0.27-2.94%
At Close: -
$8.91
00.00%
After Hours: 4:03 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$55.00
Lowest Price Target1
$15.00
Consensus Price Target1
$32.78

EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock, Analyst Ratings, Price Targets, Forecasts

EyePoint Pharmaceuticals Inc has a consensus price target of $32.78 based on the ratings of 10 analysts. The high is $55 issued by Guggenheim on May 18, 2023. The low is $15 issued by Jefferies on August 28, 2024. The 3 most-recent analyst ratings were released by Jefferies, JP Morgan, and Chardan Capital on August 28, 2024, August 13, 2024, and June 28, 2024, respectively. With an average price target of $24 between Jefferies, JP Morgan, and Chardan Capital, there's an implied 169.36% upside for EyePoint Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
2
Jun
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Jefferies
JP Morgan
Chardan Capital
HC Wainwright & Co.
Baird

1calculated from analyst ratings

Analyst Ratings for EyePoint Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for EyePoint Pharmaceuticals (EYPT) stock?

A

The latest price target for EyePoint Pharmaceuticals (NASDAQ:EYPT) was reported by Jefferies on August 28, 2024. The analyst firm set a price target for $15.00 expecting EYPT to rise to within 12 months (a possible 68.35% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for EyePoint Pharmaceuticals (EYPT)?

A

The latest analyst rating for EyePoint Pharmaceuticals (NASDAQ:EYPT) was provided by Jefferies, and EyePoint Pharmaceuticals initiated their buy rating.

Q

When was the last upgrade for EyePoint Pharmaceuticals (EYPT)?

A

There is no last upgrade for EyePoint Pharmaceuticals

Q

When was the last downgrade for EyePoint Pharmaceuticals (EYPT)?

A

There is no last downgrade for EyePoint Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for EyePoint Pharmaceuticals (EYPT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of EyePoint Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for EyePoint Pharmaceuticals was filed on August 28, 2024 so you should expect the next rating to be made available sometime around August 28, 2025.

Q

Is the Analyst Rating EyePoint Pharmaceuticals (EYPT) correct?

A

While ratings are subjective and will change, the latest EyePoint Pharmaceuticals (EYPT) rating was a initiated with a price target of $0.00 to $15.00. The current price EyePoint Pharmaceuticals (EYPT) is trading at is $8.91, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch